We found that the upregulation of AMPKα by 5-MF treatment was accompanied by increased expression of P53, indicating that P53 as a downstream effector of AMPKα signaling exerted the pharmacological protective effects of 5-MF during IV infection. The gene discussed is TP53; the disease is infection.